Gossamer Bio, Inc. Quarterly Marketable Securities, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Gossamer Bio, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2018 to Q2 2024.
  • Gossamer Bio, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $268M, a 114% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $268M +$142M +114% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $206M +$68.9M +50.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $264M +$121M +83.9% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $246M +$95.4M +63.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $125M -$2.72M -2.13% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $137M +$3.9M +2.94% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $144M +$1.89M +1.33% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $151M -$1.64M -1.08% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $128M +$64.4M +101% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $133M +$119M +873% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $142M +$115M +434% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $153M +$59.1M +63.3% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $63.5M -$50.8M -44.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $13.6M -$221M -94.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $26.6M -$240M -90% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $93.4M -$222M -70.4% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $114M -$201M -63.8% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $235M -$75.6M -24.3% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $267M +$143M +116% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $316M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $315M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $310M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $123M Dec 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.